MedTrace Logo

Pain Resilience and Holistic Health Care of Migraine

NCT04743492 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-03-12

No results posted yet for this study

Summary

The purpose of this study is to investigate how pain resilience (as a personality characteristic or a strength) moderate the efficacy of treatment for patients with migraine.

The primary objective of the current study is to explore the moderation effect of pain resilience between initial pain and the treatment outcome of the holistic healthcare programs. The investigators hypothesize that participants with higher level of pain resilience will show more improvements in the quality of life, less disability (assessed with the Migraine Disability Assessment Test, MIDAS), less frequency and lower severity of pain, and higher heart-rate variability after training. A secondary finding that can be obtained through the study is the comparison between the enhancement of heart rate variability in participants receiving different kinds of non-pharmacological therapies.

Conditions

  • Migraine Disorders

Interventions

BEHAVIORAL

cognitive behavioral therapy

cognitive behavioral therapy delivered by clinical psychologists in order to help patients gain coping skills.

Sponsors & Collaborators

  • Chung Shan Medical University

    collaborator OTHER

  • Changhua Christian Hospital

    lead OTHER

Principal Investigators

  • Ling-Jun Liu, MSc · Changhua Christian Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-16
Primary Completion
2024-02-28
Completion
2024-05-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04743492 on ClinicalTrials.gov